Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
Teladoc Health (NYSE:TDOC) has announced the issuance of inducement awards to 21 new employees following its acquisition of Catapult Health on February 28, 2025. The awards include:
- 19 Catapult Health employees received 365,282 restricted stock units and 324,270 performance stock units
- 2 additional non-executive employees received 155,523 restricted stock units and 125,523 performance stock units (with potential earnings up to 251,046 shares)
The restricted stock units vest over 2-3 years based on continued service. Performance stock units are tied to various financial and operational metrics of both companies. These awards were approved by the Compensation Committee under the 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.
Teladoc Health (NYSE:TDOC) ha annunciato l'emissione di premi di indennità a 21 nuovi dipendenti in seguito all'acquisizione di Catapult Health avvenuta il 28 febbraio 2025. I premi includono:
- 19 dipendenti di Catapult Health hanno ricevuto 365.282 unità di azioni vincolate e 324.270 unità di azioni legate alle performance
- 2 ulteriori dipendenti non esecutivi hanno ricevuto 155.523 unità di azioni vincolate e 125.523 unità di azioni legate alle performance (con guadagni potenziali fino a 251.046 azioni)
Le unità di azioni vincolate si consolidano nel corso di 2-3 anni in base al servizio continuato. Le unità di azioni legate alle performance sono collegate a vari parametri finanziari e operativi di entrambe le aziende. Questi premi sono stati approvati dal Comitato per la Compensazione nell'ambito del Piano di Indennità per l'Occupazione 2023, in conformità con la Regola 303A.08 della NYSE.
Teladoc Health (NYSE:TDOC) ha anunciado la emisión de premios de incentivo a 21 nuevos empleados tras la adquisición de Catapult Health el 28 de febrero de 2025. Los premios incluyen:
- 19 empleados de Catapult Health recibieron 365,282 unidades de acciones restringidas y 324,270 unidades de acciones de rendimiento
- 2 empleados adicionales no ejecutivos recibieron 155,523 unidades de acciones restringidas y 125,523 unidades de acciones de rendimiento (con ganancias potenciales de hasta 251,046 acciones)
Las unidades de acciones restringidas se consolidan durante 2-3 años en función del servicio continuo. Las unidades de acciones de rendimiento están vinculadas a varios indicadores financieros y operativos de ambas empresas. Estos premios fueron aprobados por el Comité de Compensación bajo el Plan de Incentivo de Inducción Laboral 2023, cumpliendo con la Regla 303A.08 de la NYSE.
텔라독 헬스 (NYSE:TDOC)는 2025년 2월 28일 카탈풋 헬스를 인수한 후 21명의 신입 직원에게 유인 보상을 발급한다고 발표했습니다. 보상 내역은 다음과 같습니다:
- 카탈풋 헬스 직원 19명이 365,282주의 제한 주식과 324,270주의 성과 주식을 받았습니다.
- 추가로 비임원 직원 2명이 155,523주의 제한 주식과 125,523주의 성과 주식을 받았으며 (최대 251,046주까지의 잠재적 수익이 있습니다)
제한 주식은 지속적인 근무를 기준으로 2-3년 동안 분할 지급됩니다. 성과 주식은 두 회사의 다양한 재무 및 운영 지표에 연계되어 있습니다. 이 보상은 NYSE 규칙 303A.08을 준수하며 2023 고용 유인 인센티브 보상 계획에 따라 보상위원회에서 승인되었습니다.
Teladoc Health (NYSE:TDOC) a annoncé l'émission de récompenses d'incitation à 21 nouveaux employés suite à son acquisition de Catapult Health le 28 février 2025. Les récompenses comprennent :
- 19 employés de Catapult Health ont reçu 365,282 unités d'actions restreintes et 324,270 unités d'actions de performance
- 2 employés supplémentaires non exécutifs ont reçu 155,523 unités d'actions restreintes et 125,523 unités d'actions de performance (avec des gains potentiels allant jusqu'à 251,046 actions)
Les unités d'actions restreintes sont acquises sur une période de 2 à 3 ans en fonction du service continu. Les unités d'actions de performance sont liées à divers indicateurs financiers et opérationnels des deux entreprises. Ces récompenses ont été approuvées par le Comité de Rémunération dans le cadre du Plan d'Incitation à l'Emploi 2023, conformément à la règle 303A.08 de la NYSE.
Teladoc Health (NYSE:TDOC) hat die Vergabe von Anreizprämien an 21 neue Mitarbeiter nach der Übernahme von Catapult Health am 28. Februar 2025 bekannt gegeben. Die Prämien umfassen:
- 19 Mitarbeiter von Catapult Health erhielten 365.282 eingeschränkte Aktieneinheiten und 324.270 leistungsabhängige Aktieneinheiten
- 2 weitere nicht-executive Mitarbeiter erhielten 155.523 eingeschränkte Aktieneinheiten und 125.523 leistungsabhängige Aktieneinheiten (mit potenziellen Erträgen von bis zu 251.046 Aktien)
Die eingeschränkten Aktieneinheiten werden über einen Zeitraum von 2-3 Jahren basierend auf dem fortgesetzten Dienstverhältnis fällig. Leistungsabhängige Aktieneinheiten sind an verschiedene finanzielle und betriebliche Kennzahlen beider Unternehmen gebunden. Diese Prämien wurden vom Vergütungsausschuss im Rahmen des 2023 Employment Inducement Incentive Award Plans genehmigt, der den NYSE-Regeln 303A.08 entspricht.
- Strategic acquisition of Catapult Health completed
- Retention incentives in place for key acquired employees
- Performance-based compensation structure aligned with company goals
- Potential dilution from 970,598 new shares (combined RSUs and PSUs)
- Additional stock-based compensation expenses
PURCHASE, NY, March 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to 21 new employees.
Effective February 28, 2025 and March 1, 2025, in connection with the acquisition of Catapult Health on February 28, 2025, 19 employees of Catapult Health were granted awards of restricted stock units covering an aggregate of 365,282 shares of Teladoc Health’s common stock, par value
Also, effective March 1, 2025, in connection with commencing employment, two additional new non-executive employees of Teladoc Health were granted awards of restricted stock units covering an aggregate of 155,523 shares of Common Stock and awards of performance stock units covering a target of 125,523 shares of Common Stock (for which up to 251,046 shares may be earned). The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The performance stock units provide a target number of shares of Common Stock that would be earned over three years based on various financial metrics.
The awards were approved by the Compensation Committee of the Board of Directors of Teladoc Health and were granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as employment inducement awards pursuant to New York Stock Exchange Rule 303A.08.
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com
FAQ
How many shares were awarded in Teladoc's (TDOC) latest inducement grants?
What is the vesting schedule for TDOC's March 2025 inducement awards?
How many Catapult Health employees received TDOC stock awards in the February 2025 acquisition?
What is the maximum number of shares that can be earned through TDOC's performance stock units for the new non-executive employees?
